2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one and Ischemia

2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one has been researched along with Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ebner, J; Ferenci, P; Rzepczynski, D; Zieve, L; Zimmermann, C	1

Other Studies

1 other study(ies) available for 2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one and Ischemia

Article	Year
A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding. Metabolic brain disease, 1987, Volume: 2, Issue:3 Topics: Animals; Benzodiazepines; Brain; Diazepam; gamma-Aminobutyric Acid; Hepatic Artery; Hepatic Encephalopathy; Ischemia; Kinetics; Liver Circulation; Male; Portacaval Shunt, Surgical; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values	1987

Article

Year

A benzodiazepine antagonist does not alter the course of hepatic encephalopathy or neural gamma-aminobutyric acid (GABA) binding.

Metabolic brain disease, 1987, Volume: 2, Issue:3

Topics: Animals; Benzodiazepines; Brain; Diazepam; gamma-Aminobutyric Acid; Hepatic Artery; Hepatic Encephalopathy; Ischemia; Kinetics; Liver Circulation; Male; Portacaval Shunt, Surgical; Pyrazoles; Rats; Rats, Inbred Strains; Receptors, GABA-A; Reference Values

1987